advertisement
11.13.2 Betablocker and carbon anhydrase inhibitor (4)
Showing records 1 to 4
Display all abstracts in classification 11.13.2 Betablocker and carbon anhydrase inhibitor
Search within classification 11.13.2 Betablocker and carbon anhydrase inhibitor46110 Brinzolamide-timolol suspension: Acceptability and side effect profile
Doherty MD; Fraser SG; Phelan PS
Clinical Ophthalmology 2011; 5: 419-423
45862 Evaluation of the effect of bimatoprost/timolol fixed combination on ocular blood flow in patients with ocular hypertension using colour Doppler imaging. Preliminary study
Garcia-Perez JL; Puerto-Hernandez B; Rebolleda Fernandez G; Munoz-Negrete FJ; Gonzalez-Gordaliza C
Archivos de la Sociedad Española de Oftalmologia 2010; 85: 131-137
46109 Efficacy and tolerability of the fixed combination of brinzolamide 1% and timolol 0.5% in daily practice
Lanzl I; Raber T
Clinical Ophthalmology 2011; 5: 291-298
46162 Signs and symptoms of ocular surface status in glaucoma patients switched from timolol 0.5% to brinzolamide 1%/timolol 0.5% fixed combination: A 6-month efficacy and tolerability, multicenter, open-label prospective study
Rossi GCM; Tinelli C; Pasinetti GM; Fusetti M; Pallavicini C; Stringa M; Vacchi S; Stringa F; Bianchi PE
Expert Opinion in Pharmacotherapy 2011; 12: 685-690
